NIHbioKAM - Kurt A. Mossberg
... Moody Foundation; Growth hormone replacement after mild traumatic brain injury. Co-Investigator, 10% inkind effort; Randall Urban, PI; 2009-11. this is a pilot project assessing the effects of recombinant growth hormone replacement in patient with TBI who are found to be deficient (hypopituitarism). ...
... Moody Foundation; Growth hormone replacement after mild traumatic brain injury. Co-Investigator, 10% inkind effort; Randall Urban, PI; 2009-11. this is a pilot project assessing the effects of recombinant growth hormone replacement in patient with TBI who are found to be deficient (hypopituitarism). ...
viral hepatitis
... the vaccines is unknown. At this time, the longest clinical trial was in adults receiving Havrix, 720 enzyme-linked immunosorbent assay units at months 0, 1, and 6, who had antibody levels of more than 20 mIU/ml for 8 years. Similar results were observed with VAQTA for up to about 6–7 years in adult ...
... the vaccines is unknown. At this time, the longest clinical trial was in adults receiving Havrix, 720 enzyme-linked immunosorbent assay units at months 0, 1, and 6, who had antibody levels of more than 20 mIU/ml for 8 years. Similar results were observed with VAQTA for up to about 6–7 years in adult ...
Epilepsy - med.muni
... Levetiracetam, Topiramate, Pregabaline (second line drugs) Zonisamide, Eslicarbazepine, Retigabine (new AEDs) ...
... Levetiracetam, Topiramate, Pregabaline (second line drugs) Zonisamide, Eslicarbazepine, Retigabine (new AEDs) ...
Antimicrobial management of presumed microbial keratitis
... The non-contact lens wearing patient infected with Ps aeruginosa may have traumatised the cornea with a mascara brush but she had been using opened, and subsequently contaminated, cosmetic eyedrops (Eyedew (adrenaline), Boots plc) while sunbathing on holiday in Spain. On return from vacation the pat ...
... The non-contact lens wearing patient infected with Ps aeruginosa may have traumatised the cornea with a mascara brush but she had been using opened, and subsequently contaminated, cosmetic eyedrops (Eyedew (adrenaline), Boots plc) while sunbathing on holiday in Spain. On return from vacation the pat ...
Potassium Disorders: Hypokalemia and Hyperkalemia
... potassium-sparing diuretics has risen since adding spironolactone to standard therapy was shown to reduce morbidity and mortality in patients with congestive heart failure.29 Dual treatment with an ACE inhibitor and an ARB increases the risk of harmful adverse effects, including hyperkalemia, and sh ...
... potassium-sparing diuretics has risen since adding spironolactone to standard therapy was shown to reduce morbidity and mortality in patients with congestive heart failure.29 Dual treatment with an ACE inhibitor and an ARB increases the risk of harmful adverse effects, including hyperkalemia, and sh ...
COSOPT - Index
... Respiratory reactions and cardiac reactions, including death due to bronchospasm in patients with asthma and rarely death in association with cardiac failure, have been reported following administration of timolol maleate ophthalmic solution. Patients with severe peripheral circulatory disturbance/ ...
... Respiratory reactions and cardiac reactions, including death due to bronchospasm in patients with asthma and rarely death in association with cardiac failure, have been reported following administration of timolol maleate ophthalmic solution. Patients with severe peripheral circulatory disturbance/ ...
Dilantin Suspension LPD Version 2.0
... Cases of acute hepatotoxicity, including infrequent cases of acute hepatic failure, have been reported with phenytoin. These incidents have been associated with a hypersensitivity syndrome characterized by fever, skin eruptions, and lymphadenopathy, and usually occur within the first 2 months of tre ...
... Cases of acute hepatotoxicity, including infrequent cases of acute hepatic failure, have been reported with phenytoin. These incidents have been associated with a hypersensitivity syndrome characterized by fever, skin eruptions, and lymphadenopathy, and usually occur within the first 2 months of tre ...
Early detection of asthma exacerbations by using action points in self-management plans
... All analyses were performed with STATA (release 11; StataCorp, College Station, TX, USA). Contingency tables for each AP threshold were constructed to calculate performance characteristics including sensitivity, specificity, accuracy and area under the receiver operating characteristic (AUC) curve f ...
... All analyses were performed with STATA (release 11; StataCorp, College Station, TX, USA). Contingency tables for each AP threshold were constructed to calculate performance characteristics including sensitivity, specificity, accuracy and area under the receiver operating characteristic (AUC) curve f ...
2011 ACCF/AHA Focused Update of the Guidelines for the Management... Patients With Unstable Angina/NonST-Elevation Myocardial Infarction
... to important science and treatment trends that could have a major impact on patient outcomes and quality of care. Evidence will be reviewed at least twice a year, and updates will be initiated on an as-needed basis and completed as quickly as possible while maintaining the rigorous methodology that ...
... to important science and treatment trends that could have a major impact on patient outcomes and quality of care. Evidence will be reviewed at least twice a year, and updates will be initiated on an as-needed basis and completed as quickly as possible while maintaining the rigorous methodology that ...
Amyotrophic Lateral Sclerosis (ALS) and Related Motor Neuron
... history and physical exam is the electrodiagnostic examination (Bashear and Elovic, 2011, Preston and Shapiro, 2005, Bertorini 2011, Kimura 2001). Clinical EMG testing characterizes motor unit action potentials during muscle contraction. A motor unit is the basic component of the peripheral nervous ...
... history and physical exam is the electrodiagnostic examination (Bashear and Elovic, 2011, Preston and Shapiro, 2005, Bertorini 2011, Kimura 2001). Clinical EMG testing characterizes motor unit action potentials during muscle contraction. A motor unit is the basic component of the peripheral nervous ...
Training
... Viljanen MK. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain 1996 Dec; 119 ( Pt 6): 2143-54. ξ Kaiser R, Rasiah C, Gassmann G, Vogt A, Lücking CH. Intrathecal antibody synthesis in Lyme neuroborreliosis: use of recombinant p41 and a 14-kDa f ...
... Viljanen MK. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain 1996 Dec; 119 ( Pt 6): 2143-54. ξ Kaiser R, Rasiah C, Gassmann G, Vogt A, Lücking CH. Intrathecal antibody synthesis in Lyme neuroborreliosis: use of recombinant p41 and a 14-kDa f ...
British Society for Rheumatology and British Health Professionals
... metatarsophalangeal joint of the great toe was the first joint to be affected in more than 50% [8] but more recent studies have documented a greater frequency of atypical monoarthritis in other lower and upper limb peripheral joints, and polyarticular gout, particularly in older women [9]. Before ur ...
... metatarsophalangeal joint of the great toe was the first joint to be affected in more than 50% [8] but more recent studies have documented a greater frequency of atypical monoarthritis in other lower and upper limb peripheral joints, and polyarticular gout, particularly in older women [9]. Before ur ...
Asthma in children < 5 years - Saudi Initiative for Asthma
... SINA is developed by a task force originated from the Saudi Initiative for Asthma Group under the umbrella of the Saudi Thoracic Society SINA is a practical approach for a comprehensive management of asthma in adults and children and when to refer to a specialist. International recommendations were ...
... SINA is developed by a task force originated from the Saudi Initiative for Asthma Group under the umbrella of the Saudi Thoracic Society SINA is a practical approach for a comprehensive management of asthma in adults and children and when to refer to a specialist. International recommendations were ...
Comparative Study of Efficacy of Glycolic Acid Peel and Intense
... Background: Melasma, one of the common aesthetically displeasing entities, continues to be a difficult problem to treat. Chemical peeling is one new weapon in the therapeutic armamentarium of melasma. Intense Pulsed Light (IPL) is a noncoherent, broad-spectrum light, ranging from 500 to 1200 nm. Int ...
... Background: Melasma, one of the common aesthetically displeasing entities, continues to be a difficult problem to treat. Chemical peeling is one new weapon in the therapeutic armamentarium of melasma. Intense Pulsed Light (IPL) is a noncoherent, broad-spectrum light, ranging from 500 to 1200 nm. Int ...
Coinfection with Hepatitis C Virus among HIV-1
... HCV can lead to reduced hepatotoxicity [28] and regression of the drawbacks such as liver fibrosis [15,29,30]. While HCV genotype and viral load can influence the response to HCV therapy, extent of hepatic fibrosis and CD4 counts are most indicative of the individuals that should be receiving HCV th ...
... HCV can lead to reduced hepatotoxicity [28] and regression of the drawbacks such as liver fibrosis [15,29,30]. While HCV genotype and viral load can influence the response to HCV therapy, extent of hepatic fibrosis and CD4 counts are most indicative of the individuals that should be receiving HCV th ...
Rifater (rifampin, isoniazid and pyrazinamide)
... develop even after many months of treatment. The risk of developing hepatitis is age related. Approximate case rates by age are: 0 per 1,000 for persons under 20 years of age, 3 per 1,000 for persons in the 20 to 34 year age group, 12 per 1,000 for persons in the 35 to 49 year age group, 23 per 1,00 ...
... develop even after many months of treatment. The risk of developing hepatitis is age related. Approximate case rates by age are: 0 per 1,000 for persons under 20 years of age, 3 per 1,000 for persons in the 20 to 34 year age group, 12 per 1,000 for persons in the 35 to 49 year age group, 23 per 1,00 ...
sanofi-aventis Canada Inc. Date of Revision: 2150 St. Elzear Blvd. West
... Clostridium difficile-associated disease (CDAD) has been reported with use of many antibacterial agents, including SUPRAX. CDAD may range in severity from mild diarrhea to fatal colitis. It is important to consider this diagnosis in patients who present with diarrhea, or symptoms of colitis, pseudom ...
... Clostridium difficile-associated disease (CDAD) has been reported with use of many antibacterial agents, including SUPRAX. CDAD may range in severity from mild diarrhea to fatal colitis. It is important to consider this diagnosis in patients who present with diarrhea, or symptoms of colitis, pseudom ...
NASPGHAN ANNUAL MEETING OCTOBER 18 – 20, 2012 SALT
... pos.). Misoprostol, furazolidone, metronidazole, exclusion diet and parenteral nutrition were added in isolated cases. One patient showed no clinical improvement; all others improved ranging from complete symptom resolution (7/17), improved dyspepsia (10/17) with intermittent symptoms (4). Follow up ...
... pos.). Misoprostol, furazolidone, metronidazole, exclusion diet and parenteral nutrition were added in isolated cases. One patient showed no clinical improvement; all others improved ranging from complete symptom resolution (7/17), improved dyspepsia (10/17) with intermittent symptoms (4). Follow up ...
COPD and Asthma: Differential Diagnosis
... decline. Ask specific questions about the patient’s well-being (e.g., by using a questionnaire such as the COPD Assessment Test) every three months. Assess symptoms (e.g., cough, sputum production, dyspnea, limitations of activity, and sleep disturbances) and smoking status at every visit. Exacerbat ...
... decline. Ask specific questions about the patient’s well-being (e.g., by using a questionnaire such as the COPD Assessment Test) every three months. Assess symptoms (e.g., cough, sputum production, dyspnea, limitations of activity, and sleep disturbances) and smoking status at every visit. Exacerbat ...
The condition
... Ataxia can also be caused by exposure to toxins such as medication or alcohol, and it can be a side-effect of a stroke, MS, or even a brain tumour. In some cases ataxia can be caused by a virus and the symptoms will go away again. For many people no cause is found; this is called ‘idiopathic ataxia’ ...
... Ataxia can also be caused by exposure to toxins such as medication or alcohol, and it can be a side-effect of a stroke, MS, or even a brain tumour. In some cases ataxia can be caused by a virus and the symptoms will go away again. For many people no cause is found; this is called ‘idiopathic ataxia’ ...
Wegener Granulomatosis (Granulomatosis with Polyangiitis
... virtually any organ can be involved. The spectrum and severity of the disease are heterogeneous, ranging from indolent disease involving only one site to fulminant, multiorgan vasculitis. The pathogenesis of WG has not been elucidated, but both cellular and humoral components are involved. Circulati ...
... virtually any organ can be involved. The spectrum and severity of the disease are heterogeneous, ranging from indolent disease involving only one site to fulminant, multiorgan vasculitis. The pathogenesis of WG has not been elucidated, but both cellular and humoral components are involved. Circulati ...
Document
... Severe sacral ulcers, to protect skin Chronic urinary retention only if renal impairment Measurement of post-void volume (if bladders scan unavailable) ...
... Severe sacral ulcers, to protect skin Chronic urinary retention only if renal impairment Measurement of post-void volume (if bladders scan unavailable) ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.